Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2021 Jul 1.

Published in final edited form as: Biomaterials. 2020 Mar 20;245:119973. doi: 10.1016/j.biomaterials.2020.119973

Table 1:

List of all hydrogel compositions used in this study.

QK:RGD ratio	Crosslinker concentration	Gelation mode
0:1	150 mg/mL GDL or 25 mM AAD/1-HOBT	Ionic (CaCO₃/GDL)
1:3	150 mg/mL GDL or 25 mM AAD/1-HOBT
1:3	167 mg/mL GDL or 42 mM AAD/1-HOBT
1:1	167 mg/mL GDL or 42 mM AAD/1-HOBT
3:1	183 mg/mL GDL or 58 mM AAD/1-HOBT	Covalent (AAD/1-HOBT/EDC)
1:0	183 mg/mL GDL or 58 mM AAD/1-HOBT
1:0	200 mg/mL GDL or 75 mM AAD/1-HOBT
Untreated	200 mg/mL GDL or 75 mM AAD/1-HOBT